Sunshine Biopharma Inc Cash Flow-to-Debt Ratio
Sunshine Biopharma Inc cash flow-to-debt ratio. Sunshine Biopharma Inc (SBFM) has a Cash Flow-to-Debt Ratio of -0.15x as of June 2026, meaning its operating cash flow of $-917.98K could theoretically repay 0% of its total liabilities ($6.09 Million) in one year. Check Sunshine Biopharma Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sunshine Biopharma Inc (2007–2025)
Cash flow-to-debt ratio of Sunshine Biopharma Inc from 2007 to 2025. Historical debt coverage capacity for Sunshine Biopharma Inc across 19 annual periods. Check SBFM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Sunshine Biopharma Inc Cash Flow-to-Debt Ratio by Year (2007–2025)
Sunshine Biopharma Inc cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Sunshine Biopharma Inc. For the full cash flow conversion analysis, see SBFM operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.76x | $-5.33 Million | $7.04 Million | ▲ +57.3% |
| 2024 | -1.78x | $-12.53 Million | $7.06 Million | ▼ -24.2% |
| 2023 | -1.43x | $-8.78 Million | $6.14 Million | ▼ -115.6% |
| 2022 | -0.66x | $-5.25 Million | $7.92 Million | ▲ +27.8% |
| 2021 | -0.92x | $-1.83 Million | $1.99 Million | ▼ -179.5% |
| 2020 | -0.33x | $-657.30K | $2.00 Million | ▲ +44.8% |
| 2019 | -0.59x | $-495.80K | $833.53K | ▼ -39.5% |
| 2018 | -0.43x | $-512.81K | $1.20 Million | ▲ +34.8% |
| 2017 | -0.65x | $-543.52K | $830.85K | ▲ +42.9% |
| 2016 | -1.15x | $-314.18K | $274.10K | ▼ -67.8% |
| 2015 | -0.68x | $-867.64K | $1.27 Million | ▲ +32.7% |
| 2014 | -1.01x | $-538.60K | $531.00K | ▲ +93.0% |
| 2013 | -14.49x | $-564.40K | $38.95K | ▼ -137.3% |
| 2012 | -6.11x | $-393.05K | $64.37K | ▲ +92.9% |
| 2011 | -86.58x | $-297.30K | $3.43K | ▼ -183.4% |
| 2010 | -30.54x | $-348.32K | $11.40K | ▼ -4175.9% |
| 2009 | -0.71x | $-10.22K | $14.31K | ▲ +29.5% |
| 2008 | -1.01x | $-23.03K | $22.74K | ▲ +51.3% |
| 2007 | -2.08x | $-3.12K | $1.50K | — |